08:00 , Dec 8, 2008 |  BC Week In Review  |  Company News

Trega Biosciences Inc. board of directors update

Trega Biosciences Inc. (TRGA), San Diego, Calif.   Business: Drug discovery   Appointed: Jeremy Levin, CEO, president and chairman of Cadus Pharmaceutical Corp. (KDUS, Tarrytown, N.Y.); and Anders Wiklund, SVP of Biacore Holding Inc., an...
07:00 , May 17, 2004 |  BC Week In Review  |  Company News

Cadus management update

Cadus Corp. (KDUS), New York, N.Y.   Business: Other   Hired: David Blitz, a retired partner of Deloitte & Touche LLP, as acting president and CEO  ...
07:00 , Apr 12, 2004 |  BC Week In Review  |  Company News

Cadus management update

Cadus Corp. (KDUS), New York, N.Y.   Business: Other   Resigned: Michele Paige as president, CEO and a director  ...
08:00 , Feb 24, 2003 |  BC Week In Review  |  Company News

Cadus Pharmaceutical Corp. deal

Cadus Technologies Inc., a subsidiary of KDUS, received a $1 million milestone from an undisclosed pharmaceutical company as part of a 2001 non-exclusive licensing deal for access to Cadus' yeast-based drug discovery technologies. Cadus Pharmaceutical...
08:00 , Feb 24, 2003 |  BC Week In Review  |  Company News

Cadus Pharmaceutical Corp. board of directors update

Cadus Pharmaceutical Corp. (KDUS), New York, N.Y.   Business: Other   Resigned: Siegfreid Schaefer  ...
08:00 , Feb 24, 2003 |  BC Week In Review  |  Company News

Cadus Pharmaceutical Corp. management update

Cadus Pharmaceutical Corp. (KDUS), New York, N.Y.   Business: Other   Resigned: Russell Glass as CEO and president, while remaining a director   Hired: Michele Paige as CEO, president and a director, formerly an investment...
08:00 , Feb 19, 2002 |  BioCentury  |  Politics, Policy & Law

Carl Icahn & other card sharks

For those who missed Friday's episode, a white knight appeared and stated his intention to sweep up the bride and carry her off into the sunset . . . The ImClone Systems Inc. saga continued...
08:00 , Feb 15, 2002 |  BC Extra  |  Top Story

Icahn seeking up to $500M of IMCL

ImClone (IMCL) said that financier Carl Icahn filed with the FTC and Department of Justice to acquire up to $500 million of IMCL stock, which would represent a 37% stake in the company, based on...
07:00 , Apr 2, 2001 |  BioCentury  |  Finance

1Q Financial Markets Review: Managing for survival

The biotech industry has entered a period in which virtually ANY publicly held company may have difficulty raising money. And while the industry isn't hurting for cash -thanks to a record $36.8 billion in fundraising...
08:00 , Nov 13, 2000 |  BC Week In Review  |  Company News

Cadus Pharmaceutical Corp., Merck enabling technology news

The U.S. District Court for the Southern District of California granted final judgement for KDUS in a 1996 patent infringement suit filed by Sibia Neurosciences Inc. , which was acquired by MRK in 1999. The...